LY393615  (Synonyms: NCC1048)

LY393615 (NCC1048) is a novel neuronal Ca²⁺ (calcium channel) and Na ⁺ channel (sodium channel) blocker with IC₅₀s of 1.9 μΜ and 5.2 μΜ for α1A and α1B calcium channel subunits. LY393615 has good brain penetration and neuroprotective effects in models of in cerebral ischemia that can be used for neurological disease research^[1].

LY393615 (0-10 μΜ) inhibits calcium flux in HEK 293 cells with α1A and α1B calcium channel subunits with IC₅₀s of 1.9 μΜ and 5.2 μΜ, and inhibits P-type calcium channels in isolated Purkinje cells with IC₅₀ of 4.0 μΜ^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

LY393615 (10 or 12.5 or 15 mg/kg; i.p., single dose) protects against hypoxiahypoglycaemic insults in brain slices and also provided significant protection against ischaemia-induced hippocampal damage in gerbil global cerebral ischaemiasup^[1]. LY393615 (15 mg/kg; i.p., 1 mg/kg; i.v.; single dose) has good brain penetration with T_1/2s of 2.04 hours (i.v.) and 2.5 hours (i.p.)^[1]. Pharmacokinetic parameters for LY393615 in Gerbils^[1]

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

381.89

C₂₁H₂₆ClF₂NO

325819-97-4

FC1=CC=C(C2(C3=CC=C(F)C=C3)CCC(CNCCCC)O2)C=C1.[H]Cl

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. O'Neill MJ, et.al. LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia. Brain Res. 2001 Jan 5;888(1):138-149.  [Content Brief]